Enliven Therapeutics

ELVN
46.5300.26% ( +0.120 )
已收盘: 11月20日 16:00:00 (美东)

股东

全部股东

股东类型

  • 机构投资者89.94%
  • 风投/私募7.78%
  • 个人与内部人士2.27%

主要股东

主要股东 最新
股东
FMR LLC
14.71%1,082.77 万1.03%+80.27 万
OrbiMed Advisors LLC
9.21%677.66 万0.04%+0
Polar Capital Holdings Plc
8.73%642.53 万0.05%-5,365.00
BlackRock, Inc.
7.76%571.20 万1.81%+135.23 万
Vanguard Capital Management, LLC
4.55%334.49 万0.51%+39.24 万
Commodore Capital LP
4.45%327.50 万0.02%+0
Vestal Point Capital, LP
4.38%322.50 万1.08%-77.50 万
T. Rowe Price Group, Inc.
3.19%235.02 万1.18%-85.46 万
Fairmount Funds Management LLC
2.52%185.56 万0.01%+0
Geode Capital Management, LLC
2.32%170.89 万0.40%+30.17 万
State Street Investment Management
2.10%154.68 万0.44%+33.32 万
Artal Group S.A.
2.00%147.52 万0.42%-29.92 万
Bellevue Asset Management AG
2.00%146.90 万0.04%-2.10 万
Adage Capital Management, L.P.
1.99%146.61 万0.51%+38.28 万
Norges Bank Investment Management
1.88%138.23 万<0.01%+0
Pictet Asset Management Limited
1.80%132.57 万0.22%+16.40 万
Citadel Advisors LLC
1.69%124.45 万1.13%-82.45 万
Marshall Wace LLP
1.57%115.54 万0.84%+62.31 万
Assenagon Asset Management S.A.
1.57%115.40 万1.15%+84.74 万
Logos Global Management, L.P.
1.47%108.00 万0.83%+61.50 万